Dec 22, 2022, 01:00 by User Not Found

Clinical Research News | Funding for microbial resistance and infectious disease research, tracking Long COVID in diverse pediatric and adult populations, an AI-powered platform that identifies novel cancer therapies and predicts the efficacy of cancer drug combinations, and more.

Dec 20, 2022, 01:00 by User Not Found

Clinical Research News | The world’s first B2B market network for clinical trials is now fully functioning and onboarding, as well as learning, from early adopters. ClinEco recently moved into the open beta stage of its development with a gratifyingly diverse mix of stakeholders registering for free membership.

Dec 19, 2022, 12:23 by

Generis has announced that Merz has selected Generis' CARA™ Life Sciences Platform for managing all the documents in their R&D process.

Dec 16, 2022, 10:20 by

Integrated Synthesis-to-Clinic® Program Will Support HTD1801’s Clinical Development and Regulatory Submission Package

Dec 15, 2022, 10:06 by

Dec 15, 2022, 10:05 by

Dec 15, 2022, 10:02 by

ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury (SCI), today reported interim clinical outcomes from the first ten[1] people treated to regulate blood pressure with implantable ARC Therapy, ONWARD’s targeted spinal cord stimulation technique. ARC Therapy immediately improved blood pressure levels for all participants; this benefit has been sustained for the duration of the current follow-up period. Participants have also reported improved quality of life, increased energy and vitality, and reduced dizziness.

Dec 15, 2022, 01:00 by User Not Found

Clinical Research News | During a recent virtual unveiling party livestreamed from around the world, Insilico Medicine introduced the latest updates to Pharma.AI, its end-to-end drug discovery platform using generative artificial intelligence to discover new targets, design new molecules, and predict the outcome of clinical trials. Among the highlights were the addition of a knowledge graph to target discovery product PandaOmics and numerous new panels to generative chemistry engine Chemistry42.

Dec 14, 2022, 10:13 by

Genomics England has announced funding of £105 million to kickstart a world-leading research study, in partnership with the NHS, to explore the effectiveness of using whole genome sequencing to find and treat rare genetic diseases in newborn babies.

Dec 14, 2022, 10:13 by

On the occasion of Thanksgiving and Christmas, Alfa Chemistry would like to express its sincere gratitude to its global customers. In addition to discounts and exquisite gifts offered to ordering customers, the company also continuously improves its product lines. Fairly recently, Alfa Chemistry announced the upgrade of its featured products, i.e., protection reagents, environmental goods standards, as well as porphyrins and phthalocyanines, supporting better user experience and wider choices for customers across the world.

Dec 14, 2022, 10:12 by

The past decade has seen exponential growth of the cosmeceutical market in the personal care industry. There is increasing use of alpha hydroxy acids for skin rejuvenation as well as the use of vitamin C in topical formulations as an antioxidant. In response to such a trend, CD Formulation recently launched one-stop OEM/ODM and analytical testing solutions for cosmetic formulations.

Dec 14, 2022, 10:11 by

Start-up trials achieved in eight to 12 weeks, a fraction of typical timeframe

Dec 14, 2022, 10:11 by

Large teaching hospital in the Netherlands relies on precision dosing platform for point-of-care decision support and immunology research

Dec 14, 2022, 01:00 by User Not Found

Clinical Research News | Researchers from Duke, Penn State, and the University of Tennessee collaboratively built a mathematical model of Alzheimer’s disease that used real, de-identified patient data to simulate health outcomes from a pair of anti-amyloid-beta drugs. Notably, the virtual (aka in silico) clinical trials employed a computational approach that provides “individualized prescriptions” based on optimal timing and dosing of treatment while minimizing possible side effects.

Dec 14, 2022, 01:00 by User Not Found

Clinical Research News | Researchers from Duke, Penn State, and the University of Tennessee collaboratively built a mathematical model of Alzheimer’s disease that used real, de-identified patient data to simulate health outcomes from a pair of anti-amyloid-beta drugs. Notably, the virtual (aka in silico) clinical trials employed a computational approach that provides “individualized prescriptions” based on optimal timing and dosing of treatment while minimizing possible side effects.

Dec 13, 2022, 10:42 by

CluePoints Appoints Andy Cooper as New Chief Executive Officer New CEO brings a combination of experience and drive as CluePoints rapidly scales its RBQM and Data Quality Oversight offerings

Dec 13, 2022, 01:00 by User Not Found

Clinical Research News | A key member of the team that discovered the BRCA2 breast cancer susceptibility gene in 1995 is now enamored of the idea of taking on cancer with synthetic lethal therapies, a nontraditional approach that exploits the weaknesses of cancer cells. The promise of the treatment concept was the topic of the Heath Memorial Award keynote address delivered at the recent Leading Edge of Cancer Research Symposium of the University of Texas MD Anderson Cancer Center.

Dec 12, 2022, 18:13 by

MultiCare Health System is the first to use the Illumicare Trials App in a clinical setting, streamlining clinical trial recruitment and increasing awareness among providers, patients and clinical research teams.

Dec 12, 2022, 18:12 by

Digital Therapeutics Alliance and Curebase release publication setting the stage for a fit-for-purpose evidence standard for digital therapeutics (DTx)

Dec 12, 2022, 18:12 by

Tesis Biosciences Announces Proposed Study of Veterans and Civilians with Mild Traumatic Brain Injury - Company in preparation for formal FDA approval submission